David Newman-Toker, M.D., Ph.D., is an internationally recognized leader in neuro-otology, acute stroke diagnosis, and diagnostic errors research. He completed his undergraduate studies at Yale University, his medical degree at University of Pennsylvania, his residency training and neuro-ophthalmology fellowship at Harvard University, his neuro-otology fellowship at Johns Hopkins University School of Medicine, and his doctoral degree in clinical research methods at the Johns Hopkins Bloomberg School of Public Health. He has served as a full-time faculty member at the Johns Hopkins University School of Medicine since 2002. He is the David Robinson Professor of Vestibular Neurology and also holds appointments in Otolaryngology, Ophthalmology, Emergency Medicine, Acute Care Nursing, Health Sciences Informatics, Epidemiology, and Health Policy & Management at Johns Hopkins. Dr. Newman-Toker is a bedside-to-populations translational researcher, with a focus on eliminating diagnostic errors and achieving diagnostic excellence. He is a leader in the national and international movements to eliminate patient harms from diagnostic error. Dr. Newman-Toker’s clinical focus is on diagnosis of acute disorders affecting the brainstem and cranial nerves, particularly stroke. He is recognized for his research in novel eye-movement-based bedside methods for diagnosing stroke in patients with acute dizziness and vertigo in the emergency department and, in 2024, won the international Bárány Society’s Hallpike-Nylén Prize for clinical research achievement. Dr. Newman-Toker serves as director of the Division of Neuro-Visual & Vestibular Disorders in the Department of Neurology. He also directs the Armstrong Institute Center for Diagnostic Excellence, whose mission is to catalyze efforts to improve diagnostic performance, develop the science of diagnostic safety, and enhance diagnostic research. He has been the principal investigator on numerous National Institutes of Health, Agency for Healthcare Research and Quality (AHRQ), and foundation grants. He has published over 165 journal articles and given more than 300 invited lectures. He has served as an expert consultant on diagnostic safety and quality to AHRQ, the National Quality Forum, and the National Academy of Medicine. He has testified before Congress on the use of artificial intelligence for medical diagnosis. He was president of the Society to Improve Diagnosis in Medicine from 2018-2020. Dr. Newman is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Stroke, and Brown Syndrome.

Neurotologist John Carey specializes in the health and diseases of the inner ear that affect both balance and hearing mechanisms. He is a national expert in superior canal dehiscence syndrome, Menière’s disease, vestibular migraine, acoustic neuromas and other causes of vertigo, and serves as chief of the Division of Otology, Neurotology and Skull Base Surgery in the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Carey earned a medical degree from Washington University School of Medicine and completed two years of training in general surgery at Virginia Mason Medical Center. This was followed by residency training in otolaryngology–head and neck surgery at University of Washington Medical Center and fellowship training in neurotology at the Johns Hopkins University School of Medicine. His research interests include superior canal dehiscence syndrome, Menière’s disease, vestibular implants, and the mechanisms of vestibular migraine. He has a particular interest in superior canal dehiscence syndrome, and, with Lloyd Minor, department director from 2003 to 2009, he helped develop the operation used to repair the superior canal. Dr. Carey has been funded by the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health. He has authored or co-authored over 150 peer-reviewed publications, 10 book chapters, and 11 reviews. Dr. Carey is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Meniere Disease, Vertigo, Acoustic Neuroma, Mastoidectomy, and Endoscopy.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

David Zee is a Neurologist in Baltimore, Maryland. Dr. Zee is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Brown Syndrome, Cerebelloparenchymal Disorder 3, and Benign Paroxysmal Positional Vertigo. Dr. Zee is currently accepting new patients.

Lawrence Whicker is a Neurologist in Greenbelt, Maryland. Dr. Whicker is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Autosomal Dominant Partial Epilepsy with Auditory Features, Memory Loss, Seizures, and Peripheral Neuropathy.

Gerard Hogan is a Radiologist in Salisbury, Maryland. Dr. Hogan is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Retroversion of the Uterus, Bronchogenic Cyst, Gallbladder Disease, and Diverticular Disease.

Kevin Berger is a Neuroradiologist in Annapolis, Maryland. Dr. Berger is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Relapsing Multiple Sclerosis (RMS), Familial Porencephaly, and Choroid Plexus Cyst.

Andrew Vennos is a Radiologist in Salisbury, Maryland. Dr. Vennos is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are CAPOS Syndrome, Pleurisy, Pleural Effusion, Bone Marrow Aspiration, and Liver Embolization.

Arthur Kane is a Neuroradiologist in Annapolis, Maryland. Dr. Kane is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Mikulicz Disease, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and Relapsing Multiple Sclerosis (RMS).

William Reid is a Neuroradiologist in Salisbury, Maryland. Dr. Reid is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Gallbladder Disease, Pleurisy, Pleural Effusion, Vertebroplasty, and Bone Graft.

William Prominski is a Radiologist in Owings Mills, Maryland. Dr. Prominski is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Herniated Disk, Scoliosis, and Hepatic Hemangioma.

Dr. Leslie F. Hao is an otolaryngologist affiliated with Sibley Memorial Hospital. She practices out of Chevy Chase ENT Associates in Chevy Chase, Md. Dr. Hao earned her medical degree from the Columbia University College of Physicians and Surgeons, where she served as the William Randolph Heart Research Fellow of the Deafness Research Foundation. She earned the Alfred Steiner Research Prize and the Harold Lamport Award for her medical student research. Dr. Hao completed a residency in otolaryngology and head and neck surgery at the University of Maryland Medical Center, where she was awarded the VA Gold Pin for outstanding patient care. Dr. Hao is a fellow of the American Academy of Otolaryngology. Dr. Hao was named a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly in 2012. She has also been named a Top Doctor by U.S. News & World Report, as well as Consumers’ Checkbook magazine. Dr. Hao is rated as a Distinguished provider by MediFind in the treatment of Vertigo. Her top areas of expertise are TMJ Disorders, Benign Paroxysmal Positional Vertigo, Jones Syndrome, and Trachoma.

Charles C. Della Santina specializes in surgery for treatment of hearing, balance and other ear disorders including otosclerosis, cholesteatoma, conductive and sensorineural hearing loss, acoustic neuroma/vestibular schwannoma, glomus and other tumors of the temporal bone, and other problems that cause hearing loss or abnormal vestibular (inner ear balance) sensation. He is the director of the Johns Hopkins Cochlear Implant Center. He performs acoustic neuroma surgery, cochlear implantation, stapes surgery, middle ear bone reconstruction, bone-conduction hearing device implantation, other middle ear and mastoid surgeries, removal of glomus and other temporal bone tumors, surgical treatment of temporal bone cerebrospinal fluid leaks and encephaloceles, and surgery for vestibular disorders including superior canal dehiscence syndrome, Meniere’s disease, bilateral loss of vestibular sensation, gentamicin ototoxicity and other disorders. Dr. Della Santina earned a medical degree from the University of California San Francisco School of Medicine and a doctorate in biomedical engineering from the University of California, Berkeley College of Engineering. He completed residency training in otolaryngology at the Johns Hopkins University School of Medicine in 2002, and has served on the Johns Hopkins faculty since then. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. His group’s world-leading research on vestibular implantation has been published in leading journals including the New England Journal of Medicine. Dr. Della Santina's more than 140 publications also include studies of inner ear physiology and anatomy, new clinical tests of vestibular function, and the effects of cochlear implantation, superior canal dehiscence syndrome and gentamicin on the inner ear. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. Dr. Della Santina's more than 110 publications also include studies of inner ear physiology and anatomy; new clinical tests of vestibular function; and the effects of cochlear implantation, superior canal dehiscence syndrome, and gentamicin on the inner ear. Dr. Santina is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Jones Syndrome, Infant Hearing Loss, DFNB1, and Vertigo.

Dr. Kathuria received his medical degree and completed his radiology residency training from Pt. B.D. Sharma Postgraduate Institute of Medical Sciences in India. To understand the impact of diseases, their prevention and cure at broad population level, he spent two years pursuing a masters in public health at University at Buffalo, SUNY. He then completed three fellowship trainings including diagnostic neuroradiology, interventional neuroradiology and advanced neuroimaging from University of Rochester, NY. He joined Johns Hopkins as a faculty member in April 2008. He went on to complete three fellowship trainings including diagnostic neuroradiology, interventional neuroradiology and advanced neuroimaging from University of Rochester, NY. He then served as a Johns Hopkins faculty member before leaving Johns Hopkins to work in a private practice. Dr. Kathuria has been recognized with awards including the 2010 Best Scientific Exhibit Award at the ASSR Annual Symposium for Percutaneous Technique in Approaching Anterior Epidural Space for Diagnosis and Therapeutic Interventions and a 2007 Certificate of Merit for diffusion tensor imaging and fiber tracking in Wallerian degeneration at the American Roentgen Ray Society Annual Meeting. Dr. Kathuria is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Herniated Disk, Scoliosis, Familial Porencephaly, Choroid Plexus Cyst, and Vertebroplasty.

Dr. Saber Tehrani is an Assistant Professor of Neurology at Johns Hopkins University School of Medicine. Dr. Saber Tehrani has unique subspecialty training in vascular neurology, neuro-ophthalmology, and vestibular neurology. He is available for consultation for patients with strokes affecting vision or balance. Research Summary Dr. Saber Tehrani’s research efforts are focused on posterior circulation stroke diagnosis and outcomes, and how such strokes can affect vision and balance. He is using novel ways to objectively measure abnormal eye movements indicative of stroke. Dr. Tehrani is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Stroke, Pica, Gastrostomy, and Stent Placement.

A leading expert on brain injury, Dr. Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996 and was named the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley founded and directed the Johns Hopkins Neurocritical Care Unit, one of the first critical care units dedicated solely to neurosurgical and neurological patients. Subsequently, in 1999, he founded and continues to direct the BIOS Clinical Trials Coordinating Center (BIOS CTCC), formerly known as the Division of Brain Injury Outcomes. Under Dr. Hanley’s leadership, BIOS CTCC, an academic contract research organization based at Johns Hopkins, has organized and completed more than 20 large clinical trials. He has been awarded over 70 clinical and basic research grants, predominantly from the National Institutes of Health and the FDA Orphan Products Grants Program. Dr. Hanley’s 40-year career in medicine has focused on clinical trial design, the organization and interpretation of drug and device trials, the development of strategic research plans, and FDA regulatory compliance. He has led international, NIH-sponsored trials including the MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics through innovative CTSA clinical trials. Currently, Dr. Hanley is the PI or multi-PI for several ongoing trials. These include a multisite phase 2/3 randomized controlled dementia prevention trial (MAP), a large multicenter clinical trial involving automated monitoring of atrial fibrillation (REACT AF), and a first-in-patient phase 2a biomarker and edema attenuation in intracerebral hemorrhage trial (BEACH). Dr. Hanley has published over 400 peer-reviewed articles and book chapters, received the Humboldt Research Prize for accomplishments in brain injury research, and mentored nearly 100 researchers. His trainees, which include a large number of trialists, have led 25 brain intensive care units, and over 40 have been named full professors, program leaders, or department chairs. He has served on public boards including the American Academy of Neurology, National Stroke Association, and NIH National Institute of Nursing Research. Dr. Hanley is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Stroke, Hydrocephalus, Vertigo, Severe Acute Respiratory Syndrome (SARS), and Thrombectomy.

Dr. Wade Chien is a fellowship-trained neuro-otologist who sees adults and children with complicated hearing and ear problems, including hearing loss; severe ear infections; vestibular schwannoma (Acoustic neuroma); and neoplasms of the ear and temporal bone. Please call 301-896-3346 for an appointment. Dr. Chien is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Hearing Loss, Infant Hearing Loss, Familial Deafness, and DFNB1.

Dr. Julianna Czum’s primary focus is cardiothoracic imaging, with clinical subspecialties in noninvasive cardiovascular and thoracic imaging. Dr. Czum earned her medical degree from UMDNJ - Robert Wood Johnson Medical School before going on to an internship at Mary Imogene Bassett Hospital and residency at St. Barnabas Medical Center. She completed a fellowship in cardiovascular magnetic resonance in a combined Henry Jackson Foundation-funded program at the National Institutes of Health, National Naval Medical Center and Uniformed Services University of the Health Sciences. Dr. Czum joined the diagnostic faculty in June 2022. Dr. Czum is rated as an Advanced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Chronic Cough, and Lung Nodules.

Dr. Marcus is a graduate of Emory University School of Medicine in Georgia. He completed his general surgery internship and Otolaryngology residency at Emory University School of Medicine. He completed a fellowship in otology and neurotology at the Silverstein Institute in Florida. Dr. Marcus is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Infant Hearing Loss, DFNB1, Cholesteatoma, and Benign Paroxysmal Positional Vertigo.

Nana Tevzadze is an Otolaryngologist in Baltimore, Maryland. Dr. Tevzadze is rated as an Advanced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Vertigo and Benign Paroxysmal Positional Vertigo.